Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae.

about

Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes.

P2860

Q55501807-B6DAB93B-DAFC-45B6-9963-BDBD6E560150

P2860

Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae.

Item

http://www.wikidata.org/entity/Q46286730

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacodynamics of fosfomycin ...... -producing Enterobacteriaceae.

@en

Pharmacodynamics of fosfomycin ...... -producing Enterobacteriaceae.

@nl

type

Item

label

Pharmacodynamics of fosfomycin ...... -producing Enterobacteriaceae.

@en

Pharmacodynamics of fosfomycin ...... -producing Enterobacteriaceae.

@nl

prefLabel

Pharmacodynamics of fosfomycin ...... -producing Enterobacteriaceae.

@en

Pharmacodynamics of fosfomycin ...... -producing Enterobacteriaceae.

@nl

P1476

Pharmacodynamics of fosfomycin ...... -producing Enterobacteriaceae.

@en

P2093

Claudia C M Lagarde

http://www.w3.org/2001/XMLSchema#string

Fiona Fransen

http://www.w3.org/2001/XMLSchema#string

Johan W Mouton

http://www.w3.org/2001/XMLSchema#string

Joseph Meletiadis

http://www.w3.org/2001/XMLSchema#string

Kelly Hermans

http://www.w3.org/2001/XMLSchema#string

Maria J B Melchers

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of fosfomycin in combination with various antistaphylococcal substances.

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

Fosfomycin: use beyond urinary tract and gastrointestinal infections.

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.

The revival of fosfomycin.

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.

What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.

Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.

P304

3374-3381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX328

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029067

http://www.w3.org/2001/XMLSchema#string

Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae.

about

P2860

P2860

Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698